Christophe Le Tourneau (Christophe le Tourneau)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 43

Top Venues

Head & neck

Cancers

Nature communications

Future oncology (London, England)

Institut Curie

Institut Curie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Curie

France

Head of Early Phase Clinical Trials :: Department of Medical Oncology

Education History

Institut Curie

France

PHD :: Department of Medical Oncology

Publications

Xavier Liem, Thierry de Baère, Omar I Vivar, Tanguy Y Seiwert, Colette Shen, Zsuzsanna Pápai, Victor Moreno, Zoltán Takácsi-Nagy, Frigyes Helfferich, Juliette Thariat, Zhen Gooi, Sue S Yom, Paolo Bossi, Robert L Ferris, Trevor G Hackman, Christophe Le Tourneau, Joseph Rodriguez, Caroline Hoffmann
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers. Head & neck 46 (6) (2024)
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet, Célia Dupain, Maud Kamal, Isabelle Guillou, Nadège Gruel, Nicolas Servant, Pierre Gestraud, Jennifer Wong, Vincent Cockenpot, Andreia Goncalves, Janick Selves, Hélène Blons, Etienne Rouleau, Olivier Delattre, Claire Gervais, Christophe Le Tourneau, Ivan Bièche, Yves Allory, Laurence Albigès, Sarah Watson
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort. NPJ precision oncology 8 (1) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Antoine Dubray-Vautrin, Guillaume Rougier, Christophe Le Tourneau, Wahib Ghanem, Nathalie Badois, Maria Lesnik, Baptiste Sabran, Laurence Bozec, Joey Martin, Olivier Choussy
Biomarkers and Prognostic Stratification of Squamous Cell Carcinoma of the Oral Cavity in Young Adults: how to personalize therapeutic management? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, Constance Lamy, Magali Lacroix-Triki, Thomas Bachelot, Thomas Filleron, Ludovic Lacroix, Alicia Tran-Dien, Pascal Jézéquel, Marjorie Mauduit, Janice Barros Monteiro, Marta Jimenez, Stefan Michiels, Valery Attignon, Isabelle Soubeyran, Keltouma Driouch, Nicolas Servant, Christophe Le Tourneau, Maud Kamal, Fabrice Andre, Ivan Bièche
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors. British journal of cancer (2024)
Monika Licaj, Rana Mhaidly, Yann Kieffer, Hugo Croizer, Claire Bonneau, Arnaud Meng, Lounes Djerroudi, Kevin Mujangi-Ebeka, Hocine R Hocine, Brigitte Bourachot, Ilaria Magagna, Renaud Leclere, Lea Guyonnet, Mylène Bohec, Coralie L Guerin, Sylvain Baulande, Maud Kamal, Christophe Le Tourneau, Fabrice Lecuru, Véronique Becette, Roman Rouzier, Anne-Vincent Salomon, Geraldine Gentric, Fatima Mechta-Grigoriou
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nature communications 15 (1) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Monika Licaj, Rana Mhaidly, Yann Kieffer, Hugo Croizer, Claire Bonneau, Arnaud Meng, Lounes Djerroudi, Kevin Mujangi-Ebeka, Hocine R Hocine, Brigitte Bourachot, Ilaria Magagna, Renaud Leclere, Lea Guyonnet, Mylène Bohec, Coralie L Guerin, Sylvain Baulande, Maud Kamal, Christophe Le Tourneau, Fabrice Lecuru, Véronique Becette, Roman Rouzier, Anne-Vincent Salomon, Geraldine Gentric, Fatima Mechta-Grigoriou
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nature communications 15 (1) (2024)
Monika Licaj, Rana Mhaidly, Yann Kieffer, Hugo Croizer, Claire Bonneau, Arnaud Meng, Lounes Djerroudi, Kevin Mujangi-Ebeka, Hocine R Hocine, Brigitte Bourachot, Ilaria Magagna, Renaud Leclere, Lea Guyonnet, Mylène Bohec, Coralie L Guerin, Sylvain Baulande, Maud Kamal, Christophe Le Tourneau, Fabrice Lecuru, Véronique Becette, Roman Rouzier, Anne-Vincent Salomon, Geraldine Gentric, Fatima Mechta-Grigoriou
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nature communications 15 (1) (2024)
Xavier Liem, Thierry de Baère, Omar I Vivar, Tanguy Y Seiwert, Colette Shen, Zsuzsanna Pápai, Victor Moreno, Zoltán Takácsi-Nagy, Frigyes Helferich, Juliette Thariat, Zhen Gooi, Sue S Yom, Paolo Bossi, Robert L Ferris, Trevor G Hackman, Christophe Le Tourneau, Joseph Rodriguez, Caroline Hoffmann
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers. Head & neck (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) (2024)
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet, Célia Dupain, Maud Kamal, Isabelle Guillou, Nadège Gruel, Nicolas Servant, Pierre Gestraud, Jennifer Wong, Vincent Cockenpot, Andreia Goncalves, Janick Selves, Hélène Blons, Etienne Rouleau, Olivier Delattre, Claire Gervais, Christophe Le Tourneau, Ivan Bièche, Yves Allory, Laurence Albigès, Sarah Watson
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort. NPJ precision oncology 8 (1) (2024)
Xavier Liem, Thierry de Baère, Omar I Vivar, Tanguy Y Seiwert, Colette Shen, Zsuzsanna Pápai, Victor Moreno, Zoltán Takácsi-Nagy, Frigyes Helfferich, Juliette Thariat, Zhen Gooi, Sue S Yom, Paolo Bossi, Robert L Ferris, Trevor G Hackman, Christophe Le Tourneau, Joseph Rodriguez, Caroline Hoffmann
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers. Head & neck 46 (6) (2024)
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet, Célia Dupain, Maud Kamal, Isabelle Guillou, Nadège Gruel, Nicolas Servant, Pierre Gestraud, Jennifer Wong, Vincent Cockenpot, Andreia Goncalves, Janick Selves, Hélène Blons, Etienne Rouleau, Olivier Delattre, Claire Gervais, Christophe Le Tourneau, Ivan Bièche, Yves Allory, Laurence Albigès, Sarah Watson
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort. NPJ precision oncology 8 (1) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) (2024)
Monika Licaj, Rana Mhaidly, Yann Kieffer, Hugo Croizer, Claire Bonneau, Arnaud Meng, Lounes Djerroudi, Kevin Mujangi-Ebeka, Hocine R Hocine, Brigitte Bourachot, Ilaria Magagna, Renaud Leclere, Lea Guyonnet, Mylène Bohec, Coralie L Guerin, Sylvain Baulande, Maud Kamal, Christophe Le Tourneau, Fabrice Lecuru, Véronique Becette, Roman Rouzier, Anne-Vincent Salomon, Geraldine Gentric, Fatima Mechta-Grigoriou
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nature communications 15 (1) (2024)
Fariba Nemati, Leanne De Koning, David Gentien, Franck Assayag, Emilie Henry, Khadija Ait Rais, Gaelle Pierron, Odette Mariani, Michèle Nijnikoff, Gabriel Champenois, André Nicolas, Didier Meseure, Sophie Gardrat, Nicolas Servant, Philippe Hupé, Maud Kamal, Christophe Le Tourneau, Sophie Piperno-Neumann, Manuel J Rodrigues, Sergio Roman-Roman, Didier Decaudin, Pascale Mariani, Nathalie Cassoux
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study. Current oncology (Toronto, Ont.) 30 (10) (2023)
Olivier Trédan, Maud Toulmonde, Christophe Le Tourneau, Laure Montane, Antoine Italiano, Isabelle L Ray-Coquard, Christelle De La Fouchardière, François Bertucci, Anthony Goncalves, Carlos Gomez-Roca, Benoit You, Valéry Attignon, Sandrine Boyault, Philippe A Cassier, Armelle Dufresne, Séverine Tabone-Eglinger, Alain Viari, Emilie Sohier, Maud Kamal, Gwenaël Garin, Jean Yves Blay, David Pérol
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort. Cancers 15 (13) (2023)
Antoine Mavrikios, Farid Goudjil, Arnaud Beddok, Sofia Zefkili, Stéphanie Bolle, Loic Feuvret, Christophe Le Tourneau, Olivier Choussy, Elisabeth Sauvaget, Philippe Herman, Rémi Dendale, Valentin Calugaru
Proton therapy and/or helical tomotherapy for locally advanced sinonasal skull base adenoid cystic carcinoma: Focus on experience of the Institut Curie and review of literature. Head & neck (2023)
Antoine Mavrikios, Farid Goudjil, Arnaud Beddok, Sofia Zefkili, Stéphanie Bolle, Loic Feuvret, Christophe Le Tourneau, Olivier Choussy, Elisabeth Sauvaget, Philippe Herman, Rémi Dendale, Valentin Calugaru
Proton therapy and/or helical tomotherapy for locally advanced sinonasal skull base adenoid cystic carcinoma: Focus on experience of the Institut Curie and review of literature. Head & neck (2023)
Wyanne A Noortman, Nicolas Aide, Dennis Vriens, Lisa S Arkes, Cornelis H Slump, Ronald Boellaard, Jelle J Goeman, Christophe M Deroose, Jean-Pascal Machiels, Lisa F Licitra, Renaud Lhommel, Alessandra Alessi, Erwin Woff, Karolien E Goffin, Christophe Le Tourneau, Jocelyn Gal, Stéphane Temam, Jean-Pierre Delord, Floris H P van Velden, Lioe-Fee De Geus-Oei
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer. Cancers 15 (10) (2023)
Antoine Mavrikios, Farid Goudjil, Arnaud Beddok, Sofia Zefkili, Stéphanie Bolle, Loic Feuvret, Christophe Le Tourneau, Olivier Choussy, Elisabeth Sauvaget, Philippe Herman, Rémi Dendale, Valentin Calugaru
Proton therapy and/or helical tomotherapy for locally advanced sinonasal skull base adenoid cystic carcinoma: Focus on experience of the Institut Curie and review of literature. Head & neck (2023)
Christophe Le Tourneau, Massimo Ghiani, Maria Chiara Cau, Roberta Depenni, Graziana Ronzino, Pierluigi Bonomo, Vincenzo Montesarchio, Luigi Leo, Jeltje Schulten, Satu Salmio, Diethelm Messinger, Andrea Sbrana, Edith Borcoman, Maria Grazia Ghi
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE. Cancer reports (Hoboken, N.J.) (2023)
Maud Kamal, Sonia Lameiras, Marc Deloger, Adeline Morel, Sophie Vacher, Charlotte Lecerf, Célia Dupain, Emmanuelle Jeannot, Elodie Girard, Sylvain Baulande, Coraline Dubot, Gemma Kenter, Ekaterina S Jordanova, Els M J J Berns, Guillaume Bataillon, Marina Popovic, Roman Rouzier, Wulfran Cacheux, Christophe Le Tourneau, Alain Nicolas, Nicolas Servant, Suzy M Scholl, Ivan Bièche, null null
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site. British journal of cancer (2023)
Bao-Tram Thi Tran, Aurore Gelin, Sylvère Durand, Matthieu Texier, Amaury Daste, Clémence Toullec, Karim Benihoud, Ingrid Breuskin, Philippe Gorphe, Florence Garic, Catherine Brenner, Christophe Le Tourneau, Jérôme Fayette, Toshiro Niki, Muriel D David, Pierre Busson, Caroline Even
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors. Oncoimmunology 12 (1) (2022)
Bao-Tram Thi Tran, Aurore Gelin, Sylvère Durand, Matthieu Texier, Amaury Daste, Clémence Toullec, Karim Benihoud, Ingrid Breuskin, Philippe Gorphe, Florence Garic, Catherine Brenner, Christophe Le Tourneau, Jérôme Fayette, Toshiro Niki, Muriel D David, Pierre Busson, Caroline Even
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors. Oncoimmunology 12 (1) (2022)
Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, Florence Dalenc, Marie-Paule Sablin, Mario Campone, Hervé Bonnefoi, Claudia Lefeuvre-Plesse, William Jacot, Florence Coussy, Jean-Marc Ferrero, George Emile, Marie-Ange Mouret-Reynier, Jean-Christophe Thery, Nicolas Isambert, Alice Mege, Philippe Barthelemy, Benoit You, Nawale Hajjaji, Ludovic Lacroix, Etienne Rouleau, Alicia Tran-Dien, Sandrine Boyault, Valery Attignon, Pierre Gestraud, Nicolas Servant, Christophe Le Tourneau, Linda Larbi Cherif, Isabelle Soubeyran, Filippo Montemurro, Alain Morel, Amelie Lusque, Marta Jimenez, Alexandra Jacquet, Anthony Gonçalves, Thomas Bachelot, Ivan Bieche
Genomics to select treatment for patients with metastatic breast cancer. Nature 610 (7931) (2022)
Caroline Hoffmann, Floriane Noel, Maximilien Grandclaudon, Lucile Massenet-Regad, Paula Michea, Philemon Sirven, Lilith Faucheux, Aurore Surun, Olivier Lantz, Mylene Bohec, Jian Ye, Weihua Guo, Juliette Rochefort, Jerzy Klijanienko, Sylvain Baulande, Charlotte Lecerf, Maud Kamal, Christophe Le Tourneau, Maude Guillot-Delost, Vassili Soumelis
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity. Nature communications 13 (1) (2022)
Bao-Tram Thi Tran, Aurore Gelin, Sylvère Durand, Matthieu Texier, Amaury Daste, Clémence Toullec, Karim Benihoud, Ingrid Breuskin, Philippe Gorphe, Florence Garic, Catherine Brenner, Christophe Le Tourneau, Jérôme Fayette, Toshiro Niki, Muriel D David, Pierre Busson, Caroline Even
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors. Oncoimmunology 12 (1) (2022)
Arnaud Beddok, Caroline Saint-Martin, Samar Krhili, Catherine Ala Eddine, Laurence Champion, Anne Chilles, Farid Goudjil, Sofia Zefkili, Malika Amessis, Dominique Peurien, Olivier Choussy, Christophe Le Tourneau, Remi Dendale, Irene Buvat, Gilles Créhange, Valentin Calugaru
Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure. Head & neck 44 (11) (2022)
Diane Evrard, Clément Dumont, Michel Gatineau, Jean-Pierre Delord, Jérôme Fayette, Chantal Dreyer, Annemilaï Tijeras-Raballand, Armand de Gramont, Jean-François Delattre, Muriel Granier, Nasredine Aissat, Marie-Line Garcia-Larnicol, Khemaies Slimane, Benoist Chibaudel, Eric Raymond, Christophe Le Tourneau, Sandrine Faivre
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study. Cancers 14 (18) (2022)
Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi, Odette Mariani, Peter Filotas, Anne-Vincent Salomon, Barbara Vodicska, Vincent Servois, Edit Varkondi, David Gentien, Dora Tihanyi, Patricia Tresca, Dora Lakatos, Nicolas Servant, Julia Deri, Pauline Du Rusquec, Csilla Hegedus, Diana Bello Roufai, Richard Schwab, Celia Dupain, Istvan T Valyi-Nagy, Christophe Le Tourneau
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial. NPJ precision oncology 5 (1) (2021)
Edith Borcoman, Gregoire Marret, Christophe Le Tourneau
Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Cancers 13 (11) (2021)
Pauline Vaflard, Xavier Paoletti, Vincent Servois, Patricia Tresca, Elvire Pons-Tostivint, Marie-Paule Sablin, Francesco Ricci, Delphine Loirat, Ségolène Hescot, Nouritza Torossian, Diana Bello Roufai, Maud Kamal, Edith Borcoman, Christophe Le Tourneau
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy. Drugs in R&D 21 (4) (2021)
Edith Borcoman, Maud Kamal, Grégoire Marret, Celia Dupain, Zahra Castel-Ajgal, Christophe Le Tourneau
HDAC Inhibition to Prime Immune Checkpoint Inhibitors. Cancers 14 (1) (2021)
Emmanuelle Jeannot, Aurélien Latouche, Claire Bonneau, Marie-Ange Calméjane, Corine Beaufort, Kirsten Ruigrok-Ritstier, Guillaume Bataillon, Linda Larbi Chérif, Celia Dupain, Charlotte Lecerf, Marina Popovic, Anne de la Rochefordière, Fabrice Lecuru, Virginie Fourchotte, Ekaterina S Jordanova, Heiko von der Leyen, Carine Tran-Perennou, Marie-Emmanuelle Legrier, Sylvain Dureau, Laurence Raizonville, Diana Bello Roufai, Christophe Le Tourneau, Ivan Bièche, Roman Rouzier, Els M J J Berns, Maud Kamal, Suzy Scholl
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Pauline Du Rusquec, Christophe Le Tourneau
Drug Development in Tissue-Agnostic Indications. Cancers 13 (11) (2021)
Ian Chau, Nicolas Penel, Andres O Soriano, Hendrick-Tobias Arkenau, Jennifer Cultrera, Rafael Santana-Davila, Emiliano Calvo, Christophe Le Tourneau, Lars Zender, Johanna C Bendell, Gu Mi, Ling Gao, Samuel Clark McNeely, Joana M Oliveira, David Ferry, Roy S Herbst, Charles S Fuchs
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial. Cancers 12 (10) (2020)
Maud Kamal, Sonia Lameiras, Marc Deloger, Adeline Morel, Sophie Vacher, Charlotte Lecerf, Célia Dupain, Emmanuelle Jeannot, Elodie Girard, Sylvain Baulande, Coraline Dubot, Gemma Kenter, Ekaterina S Jordanova, Els M J J Berns, Guillaume Bataillon, Marina Popovic, Roman Rouzier, Wulfran Cacheux, Christophe Le Tourneau, Alain Nicolas, Nicolas Servant, Suzy M Scholl, Ivan Bièche, null null
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site. British journal of cancer 124 (4) (2020)
Christophe Le Tourneau, Yungan Tao, Carlos Alberto Gomez Roca, Valerie Cristina, Edith Borcoman, Eric Deutsch, Rastislav Bahleda, Valentin Calugaru, Anouchka Modesto, Elisabeth Rouits, Kathrin Gollmer, Gregoire Vuagniaux, Philippa Crompton, Claudio Zanna, Sergio Szyldergemajn, Jean-Pierre Delord, Jean Bourhis
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Christophe Le Tourneau, Jean-Pierre Delord, Nuria Kotecki, Edith Borcoman, Carlos Gomez-Roca, Ségolène Hescot, Christiane Jungels, Anne Vincent-Salomon, Vincent Cockenpot, Lauriane Eberst, Audrey Molé, Wael Jdey, Françoise Bono, Véronique Trochon-Joseph, Hélène Toussaint, Christelle Zandanel, Olga Adamiec, Olivier de Beaumont, Philippe Alexandre Cassier
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours. British journal of cancer 123 (10) (2020)
Christophe Le Tourneau, Edith Borcoman, Maud Kamal
Molecular profiling in precision medicine oncology. Nature medicine 25 (5) (2019)

Christophe Le Tourneau.css-eqlu8i{font-size:small;padding-left:4px;} (Christophe le Tourneau)

Publication Activity (10 Years)

Top Topics

Top Venues

Christophe Le Tourneau (Christophe le Tourneau)